Foley Todd is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $4.19M.
Profile
Todd Foley is listed as an insider of Aktis Oncology, Inc. (AKTS) in SEC filings dated January 14, 2026. The filing shows no purchases or sales attributed to Foley and does not disclose his specific role within the company. Aktis Oncology is a clinical-stage oncology company developing targeted radiopharmaceuticals, including AKY-1189 and AKY-2519, for solid tumors.
Role
Insider
Notability
36/100
Board memberships
Aktis Oncology, Inc.
Awards & honors
Listed as insider in Aktis Oncology, Inc. SEC filing (2026-01-14)
Todd Foley is listed as an insider of Aktis Oncology, Inc. (AKTS) in SEC filings dated January 14, 2026. The filing shows no purchases or sales attributed to Foley and does not disclose his specific role within the company. Aktis Oncology is a clinical-stage oncology company developing targeted radiopharmaceuticals, including AKY-1189 and AKY-2519, for solid tumors.…
Has Foley Todd been buying or selling stock?
Recorded transactions: 1 open-market purchases ($4.19M) and 0 open-market sales () across all tracked filings.
Where can I see all of Foley Todd's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
